awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30353154-416B0C32-048A-46A8-A602-E88DC614D495
Q30353154-416B0C32-048A-46A8-A602-E88DC614D495
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30353154-416B0C32-048A-46A8-A602-E88DC614D495
Emerging drugs for chronic lymphocytic leukaemia.
P2860
Q30353154-416B0C32-048A-46A8-A602-E88DC614D495
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30353154-416B0C32-048A-46A8-A602-E88DC614D495
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
617db051aa5eced777ac5f1fe7457ef2c67d5ad8
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.